Browse the corpus

Cryotherapy is a commonly performed dermatologic procedure used to treat a range of benign, premalignant, and selected malignant skin lesions. The technique relies on the controlled application of extreme cold to induce tissue destruction by mechanisms such as intracellular ice crystal formation, vascular stasis, and osmotic injury. Cryotherapy is frequently used for conditions such as actinic keratoses, viral warts, seborrheic keratoses, and selected nonmelanoma skin cancers. Clinical effectiveness depends on appropriate lesion selection, accurate margin identification, and correct execution of freeze–thaw cycles. Expected postprocedural responses include erythema, blistering, and crusting, with healing typically occurring over several weeks. Potential complications include hypopigmentation, scarring, nerve injury, and recurrence, underscoring the importance of technical precision and patient counseling. This educational activity enhances clinician competence in evaluating skin lesions and applying evidence-based cryotherapy techniques. Participants learn to select appropriate candidates, determine temperature targets, choose open or contact methods, and tailor freeze–thaw cycles based on lesion type and location. The course emphasizes recognizing contraindications, managing adverse effects, and optimizing cosmetic outcomes. Structured guidance on patient education and follow-up supports safe outpatient care. Collaboration within an interprofessional team, including dermatology clinicians, advanced practice clinicians, and nursing staff, strengthens procedural safety, promotes consistent monitoring, and improves treatment outcomes through coordinated care. Objectives: Identify lesion-specific protocols, including optimal technique selection and margin control, to enhance efficacy and safety. Determine indications, contraindications, and procedural endpoints to minimize complications and recurrence. Evaluate expected healing responses following cryotherapy and identify early signs of recurrence or adverse effects. Collaborate within the interprofessional healthcare team to develop unified postprocedural care plans that promote adherence, timely reassessment, and improved patient satisfaction following cryotherapy. Access free multiple choice questions on this topic.

Cryosurgery was first described in the 1800s and has since become a mainstay of dermatologic therapy. Cryosurgery is an effective alternative to more invasive techniques and can be delivered quickly and cost-effectively in an outpatient setting. Because this is a noninvasive technique, cryosurgery can produce excellent cosmetic outcomes. Cryosurgery is performed using a cryogen, typically liquid nitrogen, to cool the targeted tissue to subzero temperatures (see Video. Cryotherapy Using Liquid Nitrogen by Cryogun). This effect induces tissue damage in 2 mechanisms. The first mechanism is the induction of tissue ischemia by damaging blood vessels and capillaries in the target area, leading to ischemic necrosis. The second mechanism damages cells more extensively by forming ice crystals, inducing osmotic cell injury, and disrupting cellular membranes. As tissue cools, ice crystals form between cells, creating an osmotic gradient that rapidly draws water out of the cells. As cooling continues, crystals form within the cell, potentially leading to cellular rupture. The thawing process also damages cells. As the tissue thaws, crystals outside the cells melt, creating a gradient that rapidly draws water back into the cells, which can cause them to swell and burst.[1][2][3] Thus, the ideal process involves rapid freezing followed by slow thawing. Cryosurgery offers an advantage over excisional techniques in the treatment of malignancies. When a malignant lesion is excised, the host is no longer exposed to the antigens present in the malignant cells. In cryosurgery, however, antigens on dead malignant cells are retained, enabling a host immune response that may lead to systemic targeting of the malignant cells.[4] The extent of tissue damage increases with each free-thaw cycle. The target temperature for destroying benign cells is −20 °C. Cancerous cells can be more resistant to cell death and require −50 °C to be destroyed. Unfortunately, melanocytes are very susceptible to thermal injury and may die at temperatures below −5 °C.[3]

The extent of tissue damage increases with each free-thaw cycle. The target temperature for destroying benign cells is −20 °C. Cancerous cells can be more resistant to cell death and require −50 °C to be destroyed. Unfortunately, melanocytes are very susceptible to thermal injury and may die at temperatures below −5 °C.[3] Zones of constant temperature are known as isotherms. In regard to cryotherapy, these are spherical zones of freezing. The radius of each isotherm is the same in all directions. For example, a −5 °C isotherm may be 10 mm from the center of freezing at both depths and at the skin surface. The −10 °C isotherm is located 5 mm from the center and represents a temperature of −10 °C at a depth of 5 mm. By knowing the target temperature and understanding isotherms, a cryosurgeon can achieve the desired temperature at a specific depth by measuring the temperature at the periphery of the freezing zone.[5] Understanding that conduction, the transfer of energy between adjacent bodies, will affect the temperature of a lesion is essential. Air is a poor conductor of heat; therefore, spraying a lesion with liquid nitrogen from a distance is less effective than holding the spray tip close to the lesion. Keratin is also a poor conductor; therefore, in cases of hyperkeratotic lesions, debulking before cryosurgery may be advisable.

Patients should be counseled about the expected outcomes following cryosurgery before the procedure. Cryosurgery induces controlled tissue injury that heals by secondary intention, which may take longer than healing after excision, particularly on the lower extremities. Healing time correlates with the depth of freezing; therefore, lesions treated more aggressively require longer recovery periods. Brief pain is common and typically lasts less than one minute. Treated areas usually progress through erythema, edema, and vesiculation over several days. Depending on treatment depth, serous exudate may persist for up to 2 weeks. Mummification or eschar formation often follows the exudative phase and may be gently debrided as appropriate. Complications of cryosurgery include dyspigmentation, alopecia, pseudoepitheliomatous hyperplasia, depressed scarring, and tissue distortion such as nail dystrophy or cartilage notching. Dyspigmentation is the most common adverse effect, with hypopigmentation most frequently observed due to melanocytes' high sensitivity to cold injury. Individuals with darker skin types may instead develop postinflammatory hyperpigmentation. Alopecia may occur when cryotherapy is performed on the scalp or other hair-bearing areas, as cold-induced damage to hair follicle bulge cells can result in permanent hair loss. Pseudoepitheliomatous hyperplasia is a benign reactive process that typically resolves spontaneously without intervention. Deep or aggressive freezing may lead to depressed scars, which often improve gradually over time. Injury to underlying structures, including the nail matrix or auricular and nasal cartilage, may result in permanent distortion or notching.

Cryosurgery is a minimally invasive dermatologic procedure that uses a cryogen, most commonly liquid nitrogen, to destroy tissue by rapid freezing and slow thawing. First described in the 1800s, it has become a mainstay of outpatient therapy because it is efficient, cost-effective, and capable of producing excellent cosmetic outcomes. Tissue injury occurs through vascular ischemia and direct cellular damage from intracellular and extracellular ice crystal formation. Benign lesions such as seborrheic keratoses, verrucae, molluscum contagiosum, and keloids may be treated with one or more freeze–thaw cycles, whereas premalignant and selected malignant lesions, including actinic keratoses and low-risk basal cell carcinoma, require lower target temperatures and wider margins. Cryosurgery is not first-line therapy for most malignancies and requires careful patient selection, understanding of isotherms, and awareness of contraindications such as vascular compromise or cold-sensitive disorders. High-quality outcomes depend on coordinated interprofessional care. Physicians and general practitioners must confirm diagnosis before treatment, select appropriate candidates, determine target temperatures and margins, and counsel patients about expected healing by secondary intention and risks such as dyspigmentation or scarring. Advanced practitioners often perform procedures in outpatient settings and should demonstrate technical proficiency, recognize complications, and arrange timely follow-up to monitor for recurrence. Nurses play a central role in patient education, equipment preparation, pain management, wound care instruction, and reinforcement of adherence across multiple sessions. Pharmacists contribute by advising on analgesics, topical anesthetics, and corticosteroids used adjunctively, while ensuring safe medication use in patients with comorbidities. Effective communication among team members regarding lesion type, freeze parameters, contraindications, and follow-up plans enhances patient safety, supports shared decision-making, and optimizes cosmetic and oncologic outcomes.